- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
A
ASND
Ascendis Pharma
164.15
3.70+2.31%After Hours: 162.21 -1.94 -1.18%18:37 04/25 EDT
OPEN/PREV CLOSE160.35/160.45
TODAY RANGE157.66-167.29
VOL560.21K
MARKET CAP9.96B
52 WEEK RANGE111.09-169.37
AVG VOL (3M)511.80K
% TURNOVER0.92%
TURNOVER--
P/E (TTM)-24.1560
% RANGE6.00%
EPS(TTM)-6.7954
P/E(FORWARD)-53.0749
P/B-90.5755
BVPS-1.8123
DIVIDEND--
P/S26.33
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.86B
SHARES OUTSTANDING60.69M
NEXT EARNINGS04/30-05/05
FREE FLOAT60.08M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·3d ago
Artisan Mid Cap Fund Q1 2025 Commentary
TipRanks·4d ago
Ascendis Pharma down about 4% in morning trading
TipRanks·04/17 10:58
Ascendis Pharma (ASND) Gets a Buy from Bank of America Securities
Dow Jones·04/16 15:14
Ascendis Pharma Initiated at Outperform by RBC Capital
Dow Jones·04/16 15:14
Ascendis Pharma Price Target Announced at $205.00/Share by RBC Capital
TipRanks·04/16 15:00
Reddit initiated, Target downgraded: Wall Street’s top analyst calls
TipRanks·04/16 10:35
Ascendis Pharma (ASND) Has a New Rating from RBC Capital
TipRanks·04/15 20:50
Ascendis Pharma initiated with an Outperform at RBC Capital
Benzinga·04/15 20:00
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Seeking Alpha·04/14 20:38
Ascendis Pharma: Rare Disease Player Is A Buy On Yorvipath Launch Trajectory
Simply Wall St·04/14 17:08
High Growth Tech Stocks In US With Potential For Expansion
TipRanks·04/14 05:46
Ascendis Pharma (ASND) Receives a Buy from Evercore ISI
Same Industry
Name/Symbol
Change%
Price